{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T05:18:17Z","timestamp":1781846297912,"version":"3.54.5"},"reference-count":127,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.eimc.2008.09.003","type":"journal-article","created":{"date-parts":[[2009,9,23]],"date-time":"2009-09-23T21:01:54Z","timestamp":1253739714000},"page":"105-115","source":"Crossref","is-referenced-by-count":44,"title":["Documento de consenso sobre el tratamiento de la bacteriemia y la endocarditis causada por Staphylococcus aureus resistente a la meticilina"],"prefix":"10.1016","volume":"27","author":[{"given":"Francisco","family":"Gudiol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benito","family":"Almirante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Mir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Cercenado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda de los \u00c1ngeles","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lex","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Vall\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Palomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Tornos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Bouza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2008.09.003_bib1","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1128\/AAC.48.11.4240-4245.2004","article-title":"Evolution of the antimicrobial resistance of Staphylococcus spp. in Spain: five nationwide prevalence studies, 1986 to 2002","volume":"48","author":"Cuevas","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib2","unstructured":"Vaqu\u00e9 J, Rosell\u00f3 J, editores. Sociedad Espa\u00f1ola de Medicina Preventiva, Salud P\u00fablica e Higiene. Evoluci\u00f3n de la prevalencia de las infecciones nosocomiales en los hospitales espa\u00f1oles. EPINE 1990-1999. Grupo de trabajo EPINE. Barcelona: Sociedad Espa\u00f1ola de Medicina Preventiva, Salud P\u00fablica e Higiene; 2001."},{"key":"10.1016\/j.eimc.2008.09.003_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1473-3099(05)70112-2","article-title":"Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat","volume":"5","author":"Zetola","year":"2005","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib4","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jama.298.15.1763","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections in the United States","volume":"298","author":"Klevens","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2008.09.003_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0213-005X(07)74242-8","article-title":"Gu\u00eda para el diagn\u00f3stico y tratamiento del paciente con bacteriemia. Gu\u00edas de la Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica (SEIMC)","volume":"25","author":"Cisneros-Herreros","year":"2007","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2008.09.003_bib6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1157\/13108709","article-title":"Recomendaciones GEIPC-SEIMC y GTEI-SEMICYUC para el tratamiento antibi\u00f3tico de infecciones por cocos grampositivos en el paciente cr\u00edtico","volume":"25","author":"Olaechea Astigarraga","year":"2007","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2008.09.003_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/clinids\/18.3.421","article-title":"Purpose of quality standars for Infectious Diseases. Infectious Diseases Society of America","volume":"18","author":"Gross","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib8","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib9","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1128\/JCM.00399-06","article-title":"Use of BBL CHROMagar MRSA medium for identification of methicillin-resistant Staphylococcus aureus directly from blood cultures","volume":"44","author":"Pape","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2008.09.003_bib10","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1128\/JCM.00552-07","article-title":"Clinical validation of the molecular BD GeneOhm Staph SR assay for direct detection of Staphylococcus aureus and methicillin-resistant S. aureus in positive blood cultures","volume":"45","author":"Stamper","year":"2007","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.eimc.2008.09.003_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00430-007-0063-0","article-title":"A multiplex real-time PCR assay for rapid detection and differentiation of 25 bacterial and fungal pathogens from whole blood samples","volume":"197","author":"Lehmann","year":"2008","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.eimc.2008.09.003_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.202.3.199","article-title":"Studies on the bacteremia of bacterial endocarditis","volume":"202","author":"Werner","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2008.09.003_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MD.0b013e31811f44ec","article-title":"Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction and sequencing directly from heart valve tissue","volume":"86","author":"Mar\u00edn","year":"2007","journal-title":"Medicine"},{"key":"10.1016\/j.eimc.2008.09.003_bib14","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1128\/JCM.01388-06","article-title":"Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period","volume":"44","author":"Wang","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2008.09.003_bib15","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2008.09.003_bib16","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1086\/430175","article-title":"Decreasing in vitro susceptibility of clinical Staphylococcus aureus isolates to vancomycin at the New York Hospital: quantitative testing redux","volume":"40","author":"Rhee","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001\u201305","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib18","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1157\/13095373","article-title":"Antimicrobial resistance surveillance: VIRA study 2006","volume":"24","author":"Picazo","year":"2006","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2008.09.003_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1157\/13120413","article-title":"Staphylococcus spp. en Espa\u00f1a: situaci\u00f3n actual y evoluci\u00f3n de la resistencia a antimicrobianos (1986\u20132006)","volume":"26","author":"Cuevas","year":"2008","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2008.09.003_bib20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1086\/346207","article-title":"Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997\u20132001","volume":"36","author":"Fridkin","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.eimc.2008.09.003_bib21","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0924-8579(00)00303-4","article-title":"Vancomycin treatment failures in Staphylococcus aureus lower respiratory tract infections","volume":"16","author":"Moise","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2008.09.003_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1086\/381202","article-title":"Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility","volume":"38","author":"Howden","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib23","unstructured":"Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI document M100-S16. Wayne, PA: CLSI, 2006."},{"key":"10.1016\/j.eimc.2008.09.003_bib24","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1128\/AAC.00939-06","article-title":"Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia","volume":"51","author":"Moise-Broder","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib26","unstructured":"Cercenado E, Cuevas O, Vindel A, Goyanes MJ, Mar\u00edn M, Bouza E. Comparison of two methods (Etest and MicroScan) for detecting vancomycin susceptibility in Staphylococcus aureus. 18th European Congress of Clinical Microbiology and Infectious Diseases. Barcelona. Spain. April 2008."},{"key":"10.1016\/j.eimc.2008.09.003_bib27","unstructured":"Perri MB, Donabedian S, Vager D, Haque N, Manierski C, Zervos M. Comparison of methods in detecting in vitro vancomycin susceptibility in methicillin-resistant Staphylococcus aureus. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. Poster D-889. Chicago (USA) 2007."},{"key":"10.1016\/j.eimc.2008.09.003_bib28","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3201\/eid1212.060505","article-title":"Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors","volume":"12","author":"Klevens","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.eimc.2008.09.003_bib29","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0924-8579(07)72175-1","article-title":"Staphylococci","volume":"29","author":"Casey","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2008.09.003_bib30","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1001\/jama.290.22.2976","article-title":"Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection","volume":"290","author":"Naimi","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2008.09.003_bib31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group","volume":"340","author":"Smith","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib32","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/JCM.01844-07","article-title":"Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan","volume":"46","author":"Huang","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.eimc.2008.09.003_bib33","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1128\/AAC.50.3.1079-1082.2006","article-title":"Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus","volume":"50","author":"Cui","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib34","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib35","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1086\/504084","article-title":"An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus","volume":"42","author":"Patel","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib36","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1086\/320001","article-title":"Guidelines for the management of intravascular catheter-related infections","volume":"32","author":"Mermel","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib37","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1157\/13056889","article-title":"Gu\u00edas para el tratamiento de las infecciones relacionadas con cat\u00e9teres intravasculares de corta permanencia en adultos: conferencia de consenso SEIMC-SEMICYUC","volume":"22","author":"Le\u00f3n","year":"2004","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2008.09.003_bib38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0002-9343(90)90290-T","article-title":"Staphylococcus aureus bacteremia in patients with Hickman catheters","volume":"89","author":"Dugdale","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib39","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archinte.155.11.1161","article-title":"Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters","volume":"155","author":"Malanoski","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib40","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/514686","article-title":"Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients","volume":"27","author":"Fowler","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib41","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0002-9343(88)80084-6","article-title":"Prospective study of infections in indwelling central venous catheters using quantitative blood cultures","volume":"85","author":"Benezra","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib42","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/bjs.1800810324","article-title":"Incidence and management of catheter-related sepsis in patients receiving home parenteral nutrition","volume":"81","author":"Williams","year":"1994","journal-title":"Br J Surg"},{"key":"10.1016\/j.eimc.2008.09.003_bib43","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/520135","article-title":"Cure of implantable venous port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal","volume":"29","author":"Rubin","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib44","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/ndt\/gfh041","article-title":"Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen","volume":"19","author":"Poole","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.eimc.2008.09.003_bib45","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/jac\/dkl103","article-title":"Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study","volume":"57","author":"Fernandez-Hidalgo","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib46","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/jac\/dkl318","article-title":"Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy","volume":"58","author":"Fort\u00fan","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1053\/j.ajkd.2007.04.014","article-title":"Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report","volume":"50","author":"Maya","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib48","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1086\/427806","article-title":"Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia","volume":"40","author":"Fowler","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib49","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/AAC.33.8.1193","article-title":"Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters","volume":"33","author":"Smith","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib50","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/infdis\/169.2.350","article-title":"A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer","volume":"169","author":"Rolston","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib51","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1086\/427283","article-title":"Efficacy and safety of weekly dalbavancin therapy for catheter-related bloodstream infection caused by gram-positive pathogens","volume":"40","author":"Raad","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib52","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/jac\/dki355","article-title":"Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies","volume":"56","author":"Shorr","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1473-3099(07)70312-2","article-title":"Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials","volume":"8","author":"Falagas","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib54","unstructured":"Tack KJ, Wilcox MH, Bouza E, Herr DH, Ijzerman MM, Croos-Dabrera RV, et al. Linezolid vs. vancomycin or oxacillin\/dicloxacillin for the treatment of catheter-related bloodstream infections (CRBSI). Program and Abstracts of 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. Chicago: American Society for Microbiology; 2007. Poster K-1748."},{"key":"10.1016\/j.eimc.2008.09.003_bib55","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7326\/0003-4819-119-4-199308150-00010","article-title":"Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis","volume":"119","author":"Jernigan","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib56","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0735-1097(97)00250-7","article-title":"Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients","volume":"30","author":"Fowler","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.eimc.2008.09.003_bib57","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10096-003-1041-0","article-title":"Management of catheter-related Staphylococcus aureus bacteremia: when may sonographic study be unnecessary?","volume":"22","author":"Pigrau","year":"2003","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/clinids\/14.1.75","article-title":"Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: a study of 55 cases and review","volume":"14","author":"Raad","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib59","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","article-title":"Clinical identifiers of complicated Staphylococcus aureus bacteremia","volume":"163","author":"Fowler","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00365540500372846","article-title":"Persistence in Staphylococcus aureus bacteremia: incidence, characteristics of patients and outcome","volume":"38","author":"Khatib","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib61","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1001\/archinte.167.17.1861","article-title":"Persistent Staphylococcus aureus bacteremia: an analysis of risk factors and outcomes","volume":"167","author":"Hawkins","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib62","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/00365540510038488","article-title":"The role of vancomycin in the persistence or recurrence of Staphylococcus aureus bacteraemia","volume":"37","author":"Siegman-Igra","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib63","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1086\/510386","article-title":"Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"44","author":"Stryjewski","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib64","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/AAC.00700-07","article-title":"Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia","volume":"52","author":"Kim","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib65","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.amjmed.2005.06.011","article-title":"Staphylococcus aureus bacteremia in patients with prosthetic devices: costs and outcomes","volume":"118","author":"Chu","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib66","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.amjmed.2004.12.017","article-title":"Risk of endocarditis among patients with prosthetic valves and Staphylococcus aureus bacteremia","volume":"118","author":"El-Ahdab","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib67","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.md.0000091185.93122.40","article-title":"A prospective multicenter study of Staphylococcus aureus bacteremia: incidence of endocarditis, risk factors for mortality, and clinical impact of methicillin resistance","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.eimc.2008.09.003_bib68","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.CCM.0B013E3181611F914","article-title":"Venous thrombosis in patients with short- and long-term central venous catheter-associated Staphylococcus aureus bacteremia","volume":"36","author":"Crowley","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib69","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-130-10-199905180-00004","article-title":"Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia","volume":"130","author":"Rosen","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib70","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s150100050065","article-title":"Metastatic complications of Staphylococcus aureus septicemia. To seek is to find","volume":"28","author":"Ringberg","year":"2000","journal-title":"Infection"},{"key":"10.1016\/j.eimc.2008.09.003_bib71","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1469-0691.2005.01359.x","article-title":"Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre","volume":"12","author":"Kaech","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2008.09.003_bib72","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/529190","article-title":"Impact of routine infectious diseases service consultation on the evaluation, management and outcomes of Staphylococcus aureus bacteremia","volume":"46","author":"Jenkins","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib73","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib74","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/AAC.01602-07","article-title":"Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib75","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/jac\/dkh076","article-title":"Antibiotic-induced persistente of cytotoxic Staphylococcus aureus in non-phagocytic cells","volume":"53","author":"Krut","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib76","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1001\/jama.279.19.1537","article-title":"Role of rifampin for treatment of orthopedic implant-related staphylococcal infections","volume":"279","author":"Zimmerli","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2008.09.003_bib77","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/424506","article-title":"A ramdomized clinical trial to compare fleroxacin-rifampin with flucloxacillin or vancomycin for the treatment of staphylococcal infection","volume":"39","author":"Schrenzel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib78","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1128\/AAC.48.10.4016-4019.2004","article-title":"In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations","volume":"48","author":"Shelburne","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib79","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","article-title":"Slow response to vancomycin or vancomycin plus rifampin in methicilln-resistant Staphylococcus aureus endocarditis","volume":"115","author":"Levine","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib80","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1128\/AAC.41.11.2497","article-title":"Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model","volume":"41","author":"Houlihan","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib81","doi-asserted-by":"crossref","first-page":"390","DOI":"10.7326\/0003-4819-117-5-390","article-title":"Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection","volume":"117","author":"Markowitz","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib82","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.47.4.1318-1323.2003","article-title":"Daptomycin pharmacokinetics and safety following administration of escalating doses once daily to healthy subjects","volume":"47","author":"Dvorchik","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib83","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.hrtlng.2007.04.003","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE) in a patient with Job's syndrome (hyperimmunoglobulin E syndrome) successfully treated with linezolid and high-dose daptomycin","volume":"37","author":"Cunha","year":"2008","journal-title":"Heart Lung"},{"key":"10.1016\/j.eimc.2008.09.003_bib84","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1128\/AAC.00247-06","article-title":"Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers","volume":"50","author":"Benvenuto","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib85","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1128\/AAC.01455-06","article-title":"Activity of daptomycin alone and in combination with rifampin and gentamicin against Staphylococcus aureus assessed by time-kill methodology","volume":"51","author":"Credito","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib86","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/jac\/dkg160","article-title":"In vitro activity of linezolid alone and in combination with gentamicin, vancomycin or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods","volume":"51","author":"Jacqueline","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib87","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ijantimicag.2004.03.013","article-title":"In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus","volume":"24","author":"Jacqueline","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.eimc.2008.09.003_bib88","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1128\/AAC.01501-05","article-title":"In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus","volume":"50","author":"Jacqueline","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib89","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0210-5691(03)79974-4","article-title":"Conclusiones de la conferencia de consenso en infecciones por cat\u00e9ter","volume":"27","author":"Ariza","year":"2003","journal-title":"Med Intensiva"},{"key":"10.1016\/j.eimc.2008.09.003_bib90","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib91","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/431979","article-title":"Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database","volume":"41","author":"Miro","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib92","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1001\/jama.293.24.3012","article-title":"Staphylococcus aureus endocarditis: a consequence of medical progress","volume":"293","author":"Fowler","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2008.09.003_bib93","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1128\/AAC.00101-07","article-title":"Impact of empirical-therapy selection on outcomes of intravenous drug users with infective endocarditis caused by methicillin-susceptible Staphylococcus aureus","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib94","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1128\/AAC.43.7.1747","article-title":"Combinations of vancomycin and beta-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin","volume":"43","author":"Climo","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib95","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ehj.2003.11.008","article-title":"Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European Society of Cardiology","volume":"25","author":"Horstkotte","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.eimc.2008.09.003_bib96","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1161\/CIRCULATIONAHA.105.165564","volume":"111","author":"Baddour","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.eimc.2008.09.003_bib97","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1128\/AAC.34.6.1227","article-title":"Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users","volume":"34","author":"Small","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib98","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/infdis\/159.5.938","article-title":"Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography","volume":"159","author":"Cremieux","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib99","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0891-5520(01)00008-3","article-title":"Infective endocarditis in intravenous drug abusers and HIV-1 infected patients","volume":"16","author":"Mir\u00f3","year":"2002","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.eimc.2008.09.003_bib100","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1128\/AAC.00510-07","article-title":"Daptomycin is effective in the treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus","volume":"52","author":"Marco","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.eimc.2008.09.003_bib101","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.amjmed.2007.07.011","article-title":"Daptomycin in the treatment of patients with infective endocarditis: experience from a registry","volume":"120","author":"Levine","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.eimc.2008.09.003_bib102","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.hrtlng.2004.07.009","article-title":"Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin","volume":"34","author":"Mohan","year":"2005","journal-title":"Heart Lung"},{"key":"10.1016\/j.eimc.2008.09.003_bib103","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1128\/AAC.47.9.3002-3004.2003","article-title":"Efficacy of linezolid alone or in combination with vancomycin for treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus","volume":"47","author":"Chiang","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib104","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1128\/AAC.46.9.3061-3064.2002","article-title":"Efficacies of quinupristin-dalfopristin combined with vancomycin in vitro and in experimental endocarditis due to methicillin-resistant Staphylococcus aureus in relation to cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics","volume":"46","author":"Pavie","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib105","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/00365540110077245","article-title":"Synercid plus vancomycin for the treatment of severe methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci infections: evaluation of 5 cases","volume":"34","author":"Sgarabotto","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib106","unstructured":"Chambers HF, Basuino L, Diep B, Steenbergen J, Zhang S, Alder J. Effect of reduced susseptibilty to daptomycin on efficacy in the rabbit model of Staphylococcus aureus aortic valve endocarditis. 47th Interscience conference on antimicrobial agents and chemotheraphy (ICCAC) September 17\u201320, 2007 Chicago IL. Abstract # B-815."},{"key":"10.1016\/j.eimc.2008.09.003_bib107","unstructured":"Miro JM, Garcia de la Maria C, Armero Y, Soy D, Moreno A, Del Rio A, et al. Daptomycin plus rifampin in the treatment of experimental endocarditis (EE) due to methicillin-resistant Staphylococcus aureus (MRSA). 47th Interscience Conference on Antimicrobial Agents and Chemotheraphy (ICCAC) September 17\u201320, 2007 Chicago IL. Abstract # B-816."},{"key":"10.1016\/j.eimc.2008.09.003_bib108","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1128\/AAC.00510-07","article-title":"Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus","volume":"52","author":"Marco","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib109","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1128\/AAC.39.2.525","article-title":"Right-sided endocarditis caused by Staphylococcus aureus in drug abusers","volume":"39","author":"Fort\u00fan","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.eimc.2008.09.003_bib110","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1007\/BF01644232","article-title":"Cefotaxime in combination with other antibiotics for the treatment of severe methicillin-resistant staphylococcal infections","volume":"13","author":"Portier","year":"1985","journal-title":"Infection"},{"key":"10.1016\/j.eimc.2008.09.003_bib111","unstructured":"Garcia de la Maria C, Marco F, Miro JM, Armero Y, Jimenez-Alzate MP, Diaz ME, et al. Efficacy of Fosfomycin plus Imipenem or Ceftriaxone Combination in the Treatment of Experimental Endocarditis due to Methicillin Resistant or Glycopeptide Intermediate Resistant Staphylococcus aureus. 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago Ill. 2003 Sep 14\u201317; abstract no. B-1091."},{"key":"10.1016\/j.eimc.2008.09.003_bib112","unstructured":"Marco F, Miro JM, Del Rio A, Garcia C, Gavalda J, Dern E, et al. Efficacy of Fosfomycin plus Imipenem or Ceftriaxone Combinations in the Treatment of Endocarditis due to Methicillin- Resistant Staphylococcus aureus. 40th. Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Toronto, Canada 2000 Sep 17\u201320."},{"key":"10.1016\/j.eimc.2008.09.003_bib113","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1469-0691.2006.01585.x","article-title":"Linezolid therapy for infective endocarditis","volume":"13","author":"Mu\u00f1oz","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2008.09.003_bib114","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.athoracsur.2007.02.096","article-title":"Early switch from vancomycin to oral linezolid for treatment of gram-positive heart valve endocarditis","volume":"84","author":"Colli","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.eimc.2008.09.003_bib115","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/AAC.44.7.1789-1795.2000","article-title":"Quinupristin-dalfopristin combined with beta-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics","volume":"44","author":"Vouillamoz","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib116","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/AAC.45.4.1244-1248.2001","article-title":"Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics","volume":"45","author":"Zarrouk","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib117","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/AAC.48.3.1061-1064.2004","article-title":"Activities of dalbavancin in vitro and in a rabbit model of experimental endocarditis due to Staphylococcus aureus with or without reduced susceptibility to vancomycin and teicoplanin","volume":"48","author":"Lefort","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib118","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1128\/AAC.42.4.981","article-title":"Efficacy of LY333328 against experimental methicillin-resistant Staphylococcus aureus endocarditis","volume":"42","author":"Kaatz","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib119","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/AAC.01266-06","article-title":"Efficacy of telavancin in the treatment of experimental endocarditis due to glycopeptide-intermediate Staphylococcus aureus","volume":"51","author":"Mir\u00f3","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib120","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1128\/AAC.44.11.3022-3027.2000","article-title":"Therapeutic efficacy of GAR-936, a novel glycylcycline, in a rat model of experimental endocarditis","volume":"44","author":"Murphy","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib121","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1128\/AAC.46.1.171-177.2002","article-title":"BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis","volume":"46","author":"Entenza","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib122","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1128\/AAC.01242-06","article-title":"In vivo efficacy of ceftaroline (PPI-0903), a new broad-spectrum cephalosporin, compared with linezolid and vancomycin against methicillin-resistant and vancomycin-intermediate Staphylococcus aureus in a rabbit endocarditis model","volume":"51","author":"Jacqueline","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib123","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1128\/AAC.42.6.1355","article-title":"Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis","volume":"42","author":"Climo","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib124","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/AAC.48.1.86-92.2004","article-title":"Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci","volume":"48","author":"Entenza","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/AAC.45.1.208-211.2001","article-title":"In vivo activity of evernimicin (SCH 27899) against methicillin-resistant Staphylococcus aureus in experimental infective endocarditis","volume":"45","author":"Boucher","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.eimc.2008.09.003_bib126","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1086\/516378","article-title":"Staphylococcus aureus prosthetic valve endocarditis: optimal management and risk factors for death","volume":"26","author":"John","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2008.09.003_bib127","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1086\/383035","article-title":"Prognostic factors in 61 cases of Staphylococcus aureus prosthetic valve infective endocarditis from the International Collaboration on Endocarditis Merged Database","volume":"38","author":"Chirouze","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X08000190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X08000190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T20:21:58Z","timestamp":1558556518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X08000190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":127,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0213005X08000190"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2008.09.003","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}